| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 8 | |
| #2 | Republic of Korea | 7 | |
| #3 | United States | 7 | |
| #4 | EPO (European Patent Office) | 6 | |
| #5 | China | 5 | |
| #6 | Canada | 4 | |
| #7 | Israel | 4 | |
| #8 | Japan | 3 | |
| #9 | Mexico | 3 | |
| #10 | WIPO (World Intellectual Property Organization) | 3 | |
| #11 | Brazil | 2 | |
| #12 | New Zealand | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Basic materials chemistry |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Sugars | |
| #5 | Coating compositions |
| # | Name | Total Patents |
|---|---|---|
| #1 | Nestor John J | 41 |
| #2 | John J Nestor | 8 |
| #3 | Nestor John | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA3086918A1 | Improved peptide pharmaceuticals for treatment of nash and other disorders | |
| WO2015184177A1 | Improved peptide pharmaceuticals for insulin resistance | |
| MX2015006336A | Improved peptide pharmaceuticals for insulin resistance. | |
| AU2012255116A1 | Improved peptide pharmaceuticals | |
| EP2710031A2 | Improved peptide pharmaceuticals for insulin resistance |